- Home
- HBM vs RGC Comparison
HBM vs RGC Comparison
Compare HBM & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HBM | RGC |
|---|---|---|
| Founded | 1927 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 11.5B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HBM | RGC |
|---|---|---|
| Price | $29.02 | $24.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 5.4M | 88.7K |
| Earning Date | 05-01-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.66 | N/A |
| Revenue Next Year | $14.54 | N/A |
| P/E Ratio | $21.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.93 | $9.39 |
| 52 Week High | $28.74 | $950.00 |
Technical Indicators
Market Signals| Indicator | HBM | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 67.28 | 38.94 |
| Support Level | $22.86 | $21.81 |
| Resistance Level | N/A | $26.42 |
| Average True Range (ATR) | 1.33 | 1.91 |
| MACD | 0.31 | -0.45 |
| Stochastic Oscillator | 98.29 | 12.88 |
Price Performance
Historical ComparisonAbout HBM Hudbay Minerals Inc. (Canada)
Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.